PL2997158T3 - Sposób wyznaczania ryzyka powstania toksyczności wywołanej promieniowaniem po ekspozycji na promieniowanie - Google Patents
Sposób wyznaczania ryzyka powstania toksyczności wywołanej promieniowaniem po ekspozycji na promieniowanieInfo
- Publication number
- PL2997158T3 PL2997158T3 PL14721386T PL14721386T PL2997158T3 PL 2997158 T3 PL2997158 T3 PL 2997158T3 PL 14721386 T PL14721386 T PL 14721386T PL 14721386 T PL14721386 T PL 14721386T PL 2997158 T3 PL2997158 T3 PL 2997158T3
- Authority
- PL
- Poland
- Prior art keywords
- radiation
- exposure
- risk
- determining
- induced toxicity
- Prior art date
Links
- 206010073306 Exposure to radiation Diseases 0.000 title 1
- 230000005855 radiation Effects 0.000 title 1
- 230000001988 toxicity Effects 0.000 title 1
- 231100000419 toxicity Toxicity 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Surgery (AREA)
- Urology & Nephrology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13167540.7A EP2803733A1 (en) | 2013-05-13 | 2013-05-13 | Method for determining the risk of developing severe dyspnea after radiation therapy |
| EP14721386.2A EP2997158B1 (en) | 2013-05-13 | 2014-05-05 | Method for determining the risk of developing radiation-induced toxicity after exposure to radiation |
| PCT/EP2014/059089 WO2014184028A1 (en) | 2013-05-13 | 2014-05-05 | Method for determining the risk of developing radiation-induced toxicity after exposure to radiation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2997158T3 true PL2997158T3 (pl) | 2018-01-31 |
Family
ID=48325515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14721386T PL2997158T3 (pl) | 2013-05-13 | 2014-05-05 | Sposób wyznaczania ryzyka powstania toksyczności wywołanej promieniowaniem po ekspozycji na promieniowanie |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20160160287A1 (pl) |
| EP (2) | EP2803733A1 (pl) |
| CA (1) | CA2910924A1 (pl) |
| DK (1) | DK2997158T3 (pl) |
| ES (1) | ES2644325T3 (pl) |
| NO (1) | NO2997158T3 (pl) |
| PL (1) | PL2997158T3 (pl) |
| WO (1) | WO2014184028A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220065863A1 (en) * | 2017-12-11 | 2022-03-03 | Georgetown University | Predictive biomarkers for adverse effects of radiation therapy |
| EP3714937A1 (en) * | 2019-03-28 | 2020-09-30 | Koninklijke Philips N.V. | Determining hematologic toxicity risk following radiotherapy |
| EP4456979A4 (en) * | 2021-12-30 | 2025-12-31 | Rhode Island Hospital | GLIOBLASTOMA TREATMENT METHODS MINIMIZING RADIATION DAMAGE IN SENSITIVE PATIENTS |
| IL327223A (en) * | 2023-09-21 | 2026-05-01 | Univ Texas | Novel mitochondria targeting signal peptides and their uses |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070190534A1 (en) * | 2001-06-11 | 2007-08-16 | Genesis Genomics Inc. | Mitochondrial sites and genes associated with prostate cancer |
-
2013
- 2013-05-13 EP EP13167540.7A patent/EP2803733A1/en not_active Withdrawn
-
2014
- 2014-05-05 CA CA2910924A patent/CA2910924A1/en not_active Abandoned
- 2014-05-05 DK DK14721386.2T patent/DK2997158T3/da active
- 2014-05-05 US US14/890,411 patent/US20160160287A1/en not_active Abandoned
- 2014-05-05 PL PL14721386T patent/PL2997158T3/pl unknown
- 2014-05-05 NO NO14721386A patent/NO2997158T3/no unknown
- 2014-05-05 WO PCT/EP2014/059089 patent/WO2014184028A1/en not_active Ceased
- 2014-05-05 EP EP14721386.2A patent/EP2997158B1/en not_active Not-in-force
- 2014-05-05 ES ES14721386.2T patent/ES2644325T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| NO2997158T3 (pl) | 2017-12-23 |
| WO2014184028A1 (en) | 2014-11-20 |
| CA2910924A1 (en) | 2014-11-20 |
| ES2644325T3 (es) | 2017-11-28 |
| EP2997158B1 (en) | 2017-07-26 |
| US20160160287A1 (en) | 2016-06-09 |
| EP2997158A1 (en) | 2016-03-23 |
| DK2997158T3 (da) | 2017-11-06 |
| EP2803733A1 (en) | 2014-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10202101355PA (en) | Method and system for gross settlement by use of an opaque blockchain | |
| IL240009A0 (en) | 193 nm laser and test system | |
| IL239679A0 (en) | Imaging device with scene-adapted automatic exposure compensation | |
| HUE049191T2 (hu) | Eljárás radioaktív jód ártalmatlanítására | |
| GB2522983B (en) | Method and apparatus for radiation dosimetry utilizing fluorescent imaging with precision correction | |
| ZA202001575B (en) | System for measuring components of solar radiation | |
| HUE053751T2 (hu) | Eljárás iopamidol elõállítására | |
| GB2544118B (en) | Inspection of nuclear waste | |
| IL235115A (en) | Method for Preparing Imidodisulfuryl Compounds | |
| DK3024816T3 (da) | Ppar-sparende forbindelser til behandling af metaboliske sygdomme | |
| GB2520086B (en) | Method of measuring isotope ratio | |
| DK2997158T3 (da) | Fremgangsmåde til bestemmelse af risikoen for udvikling af strålingsinduceret toksicitet efter eksponering for stråling | |
| EP3047306A4 (en) | Radiation exposure self test (rest) - optimized personal dosimetry and kiosk for reliably indicating exposure to radiation | |
| GB201802885D0 (en) | Method of neutron tomography | |
| GB201600208D0 (en) | Radiation imaging | |
| TWI560311B (en) | Method for forming film | |
| ZA201600408B (en) | Formulation of metaxalone | |
| ZA201600480B (en) | Methods for reducing the occurrence of hot flashes | |
| ZA201600764B (en) | Method for long-term storage of waste nuclear | |
| GB201301975D0 (en) | New method for the purpose of safening | |
| EP2984504A4 (en) | RADIATION DETECTOR AND METHOD | |
| DE102014100152A8 (de) | Kontrollwaagengestell | |
| PL2950468T3 (pl) | Określanie ekspozycji na promieniowanie | |
| GB2520205B (en) | Method & apparatus for fast determination of unknown radiation dose | |
| TH1501002313B (th) | วิธีการประเมินปริมาณการคืนตัว |